From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Sep 23

PMID 36142787

Authors

Zhiwen Wang

Chun Zhang

Affiliations

Soon will be listed here.

Abstract

Acute kidney injury (AKI) is defined as a pathological condition in which the glomerular filtration rate decreases rapidly over a short period of time, resulting in changes in the physiological function and tissue structure of the kidney. An increasing amount of evidence indicates that there is an inseparable relationship between acute kidney injury and chronic kidney disease (CKD). With the progress in research in this area, researchers have found that the recovery of AKI may also result in the occurrence of CKD due to its own maladaptation and other potential mechanisms, which involve endothelial cell injury, inflammatory reactions, progression to fibrosis and other pathways that promote the progress of the disease. Based on these findings, this review summarizes the occurrence and potential mechanisms of maladaptive repair in the progression of AKI to CKD and explores possible treatment strategies in this process so as to provide a reference for the inhibition of the progression of AKI to CKD.

Citing Articles

An adoptive cell therapy with TREM2-overexpressing macrophages mitigates the transition from acute kidney injury to chronic kidney disease.

Zhang Y, Liu Y, Luo S, Liang H, Guo C, Du Y Clin Transl Med. 2025; 15(3):e70252.

PMID: 40000418 PMC: 11859120. DOI: 10.1002/ctm2.70252.

Nanomaterials for targeted therapy of kidney diseases: Strategies and advances.

Wang Z, Zhang C Mater Today Bio. 2025; 31:101534.

PMID: 39990736 PMC: 11846943. DOI: 10.1016/j.mtbio.2025.101534.

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway.

Yang J, Yuan L, Li L, Liu F, Liu J, Chen Y Theranostics. 2025; 15(6):2544-2563.

PMID: 39990216 PMC: 11840734. DOI: 10.7150/thno.102559.

Acute Kidney Injury in Autoimmune-Mediated Rheumatic Diseases.

Patschan D, Schmalz G, Safi W, Stasche F, Matyukhin I, Ritter O J Clin Med Res. 2025; 17(2):67-75.

PMID: 39981340 PMC: 11835554. DOI: 10.14740/jocmr6149.

Intermittent Fasting Protects Against the Progression from Acute Kidney Injury to Chronic Kidney Disease.

Jang Y, Kim Y, Kim S, Lee D, Lee S, Kim I Antioxidants (Basel). 2025; 14(1.

PMID: 39857453 PMC: 11763339. DOI: 10.3390/antiox14010119.

References

Wing M, Ramezani A, Gill H, Devaney J, Raj D . Epigenetics of progression of chronic kidney disease: fact or fantasy?. Semin Nephrol. 2013; 33(4):363-74. PMC: 3885870. DOI: 10.1016/j.semnephrol.2013.05.008. View

Kulkarni O, Hartter I, Mulay S, Hagemann J, Darisipudi M, Kumar Vr S . Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol. 2014; 25(5):978-89. PMC: 4005301. DOI: 10.1681/ASN.2013050528. View

Kapitsinou P, Jaffe J, Michael M, Swan C, Duffy K, Erickson-Miller C . Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am J Physiol Renal Physiol. 2012; 302(9):F1172-9. PMC: 3362175. DOI: 10.1152/ajprenal.00667.2011. View

Thakar C, Arrigain S, Worley S, Yared J, Paganini E . A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2004; 16(1):162-8. DOI: 10.1681/ASN.2004040331. View

Su H, Ye C, Lei C, Tang H, Zeng J, Yi F . Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure. FASEB J. 2020; 34(1):1620-1636. DOI: 10.1096/fj.201901412R. View

Bechtel W, McGoohan S, Zeisberg E, Muller G, Kalbacher H, Salant D . Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010; 16(5):544-50. PMC: 3106179. DOI: 10.1038/nm.2135. View

Liu B, Tang T, Lv L, Lan H . Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018; 93(3):568-579. DOI: 10.1016/j.kint.2017.09.033. View

Simon N, Hertig A . Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis. Front Med (Lausanne). 2015; 2:52. PMC: 4525064. DOI: 10.3389/fmed.2015.00052. View

Humphreys B, Valerius M, Kobayashi A, Mugford J, Soeung S, Duffield J . Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008; 2(3):284-91. DOI: 10.1016/j.stem.2008.01.014. View

10.

Canaud G, Bonventre J . Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol Dial Transplant. 2014; 30(4):575-83. PMC: 4370290. DOI: 10.1093/ndt/gfu230. View

11.

Ma Z, Wei Q, Dong G, Huo Y, Dong Z . DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cells. Biochim Biophys Acta. 2014; 1842(7):1088-96. PMC: 4038345. DOI: 10.1016/j.bbadis.2014.04.002. View

12.

Hamanaka R, Chandel N . Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol. 2009; 21(6):894-9. PMC: 2787901. DOI: 10.1016/j.ceb.2009.08.005. View

13.

Basile D, Donohoe D, Roethe K, Mattson D . Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol. 2002; 284(2):F338-48. DOI: 10.1152/ajprenal.00169.2002. View

14.

Reddy M, Natarajan R . Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int. 2015; 88(2):250-61. PMC: 4522401. DOI: 10.1038/ki.2015.148. View

15.

Giordano A, Galderisi U, Marino I . From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007; 211(1):27-35. DOI: 10.1002/jcp.20959. View

16.

Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P . Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014; 15(2):135-47. DOI: 10.1038/nrm3737. View

17.

Basu A, Krishnamurthy S . Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids. 2010; 2010. PMC: 2929606. DOI: 10.4061/2010/201367. View

18.

Allam R, Scherbaum C, Darisipudi M, Mulay S, Hagele H, Lichtnekert J . Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012; 23(8):1375-88. PMC: 3402284. DOI: 10.1681/ASN.2011111077. View

19.

Eckardt K, Bernhardt W, Weidemann A, Warnecke C, Rosenberger C, Wiesener M . Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl. 2005; (99):S46-51. DOI: 10.1111/j.1523-1755.2005.09909.x. View

20.

Novitskaya T, McDermott L, Zhang K, Chiba T, Paueksakon P, Hukriede N . A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Am J Physiol Renal Physiol. 2013; 306(5):F496-504. PMC: 3949031. DOI: 10.1152/ajprenal.00534.2013. View